Euroapi SAS Cash Flow Conversion Efficiency
Euroapi SAS cash flow conversion efficiency. Based on the latest financial reports, Euroapi SAS (EAPI) has a cash flow conversion efficiency ratio of -0.139x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-65.50 Million ≈ $-76.58 Million USD) by net assets (€470.40 Million ≈ $549.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Euroapi SAS (2019–2025)
Cash flow conversion efficiency of Euroapi SAS from 2019 to 2025. This chart illustrates how Euroapi SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Euroapi SAS (EAPI) share price today for real-time trading data and today's change.
Euroapi SAS Cash Flow Conversion Ratio Explained
Euroapi SAS cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Euroapi SAS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Euroapi SAS ranked by their cash flow conversion efficiency. Also see how much is Euroapi SAS worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
United Bancorp Inc
NASDAQ:UBCP
|
0.013x |
|
INITECH Co. Ltd
KQ:053350
|
-0.003x |
|
WINS Co. Ltd
KQ:136540
|
0.022x |
|
ATHOS IMMO (IJM.SG)
STU:IJM
|
N/A |
|
Hana Financial 7 SPAC
KQ:230240
|
-0.051x |
|
ST Dupont
PA:DPT
|
-0.078x |
|
FM Global Logistics Holdings Bhd
KLSE:7210
|
0.028x |
|
AMCON Distributing Company
NYSE MKT:DIT
|
0.122x |
Annual Cash Flow Conversion Efficiency for Euroapi SAS (2019–2025)
The table below shows the annual cash flow conversion efficiency of Euroapi SAS from 2019 to 2025. Review Euroapi SAS free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €788.00 Million ≈ $921.25 Million |
€125.50 Million ≈ $146.72 Million |
0.159x | +27.45% |
| 2024-12-31 | €983.50 Million ≈ $1.15 Billion |
€122.90 Million ≈ $143.68 Million |
0.125x | +2173.08% |
| 2023-12-31 | €927.70 Million ≈ $1.08 Billion |
€5.10 Million ≈ $5.96 Million |
0.005x | -86.38% |
| 2022-12-31 | €1.11 Billion ≈ $1.30 Billion |
€44.80 Million ≈ $52.38 Million |
0.040x | -42.91% |
| 2021-12-31 | €1.01 Billion ≈ $1.18 Billion |
€71.50 Million ≈ $83.59 Million |
0.071x | -27.75% |
| 2020-12-31 | €989.40 Million ≈ $1.16 Billion |
€96.80 Million ≈ $113.17 Million |
0.098x | +185.41% |
| 2019-12-31 | €1.02 Billion ≈ $1.19 Billion |
€34.90 Million ≈ $40.80 Million |
0.034x | -- |
About Euroapi SAS
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that use solid phase chemistry; … Read more